Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073473 | SCV001239016 | uncertain significance | Retinal dystrophy | 2019-03-11 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV001376422 | SCV001573551 | uncertain significance | Retinitis pigmentosa 25 | 2021-04-08 | criteria provided, single submitter | research | The EYS c.-448+5G>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PM3. Based on this evidence we have classified this variant as Variant of Uncertain Significance. |
Labcorp Genetics |
RCV002554664 | SCV003439496 | uncertain significance | not provided | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 1 of the EYS gene. It does not directly change the encoded amino acid sequence of the EYS protein. This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has been observed in individual(s) with EYS-related conditions (PMID: 24265693). ClinVar contains an entry for this variant (Variation ID: 865902). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001376422 | SCV004192953 | likely pathogenic | Retinitis pigmentosa 25 | 2024-02-09 | criteria provided, single submitter | clinical testing |